一项旨在提高梅毒患者 HIV 暴露前预防(PrEP)使用率的初级保健干预措施。

A Primary Care Intervention to Increase HIV Pre-Exposure Prophylaxis (PrEP) Uptake in Patients with Syphilis.

机构信息

12259Boston University School of Medicine and Boston Medical Center, Boston, MA, USA.

12259Boston Medical Center, Boston, MA, USA.

出版信息

J Int Assoc Provid AIDS Care. 2022 Jan-Dec;21:23259582211073393. doi: 10.1177/23259582211073393.

Abstract

Identifying candidates for HIV pre-exposure prophylaxis (PrEP) is a barrier to improving PrEP uptake in priority populations. Syphilis infection is an indication for PrEP in all individuals and can be easily assessed by primary care providers (PCP) and health systems. This retrospective study evaluated the impact of a multidisciplinary provider outreach intervention on PrEP uptake in patients with a positive syphilis test result in a safety-net hospital-based primary care practice. The PCPs of PrEP-eligible patients with a positive syphilis result were notified via the electronic medical record (EMR) about potential PrEP eligibility and institutional HIV PrEP resources. Rates of PrEP offers and prescriptions were compared in the pre (8/1/2018-12/31/2018,  = 60) and post (1/1/2019-5/31/2019,  = 86) intervention periods. Secondary analyzes evaluated receipt of appropriate syphilis treatment and contemporaneous screening for HIV, gonorrhea, and chlamydia. No significant differences in the overall proportion of patients offered (15% vs 19%) and prescribed (7% vs 5%) PrEP were observed between the pre- and post-periods. Overall, 7% of positive tests represented infectious syphilis. The rate of appropriate syphilis treatment was equivalent (57% vs 56%) and contemporaneous screening for other sexually transmitted infections was suboptimal across the entire study period. Although any positive syphilis test may be an easily abstracted metric from the EMR, this approach was inclusive of many patients without current HIV risk and did not increase PrEP uptake significantly. Future research into population health approaches to increase HIV prevention should focus on patients with infectious syphilis and other current risk factors for incident HIV infection.

摘要

识别艾滋病毒暴露前预防 (PrEP) 的候选人是提高重点人群 PrEP 覆盖率的障碍。梅毒感染是所有个体使用 PrEP 的指征,并且可以由初级保健提供者 (PCP) 和卫生系统轻松评估。这项回顾性研究评估了多学科提供者外展干预对安全网医院初级保健实践中梅毒检测阳性患者接受 PrEP 的影响。PCP 通过电子病历 (EMR) 通知有资格接受 PrEP 的梅毒检测阳性患者有关潜在 PrEP 资格和机构 HIV PrEP 资源的信息。在干预前(2018 年 8 月 1 日至 12 月 31 日,n=60)和干预后(2019 年 1 月 1 日至 5 月 31 日,n=86)期间,比较了 PrEP 提供和处方的比例。二次分析评估了接受适当的梅毒治疗和同时筛查 HIV、淋病和衣原体的情况。在干预前后期间,接受 PrEP 提供的患者比例(15%对 19%)和处方比例(7%对 5%)没有显著差异。总体而言,阳性检测的 7%代表传染性梅毒。适当的梅毒治疗率是等效的(57%对 56%),在整个研究期间,其他性传播感染的同时筛查情况并不理想。尽管从 EMR 中提取任何阳性梅毒检测结果可能很容易,但这种方法包括许多当前没有 HIV 风险的患者,并且没有显著增加 PrEP 的使用率。未来应该关注具有传染性梅毒和其他 HIV 感染新发病例当前风险因素的患者,研究增加 HIV 预防的人群健康方法。

相似文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索